Efficacy and Safety Study of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH)

NCT01553721 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: udenafil
DRUG: placebo

Sponsor

Dong-A ST Co., Ltd.